The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ARBUTUS BIOPHARMA CORP | COM | 03879J100 | 96,403 | 20,168 | SH | SOLE | 20,168 | 0 | 0 | ||
| ISHARES TR | CORE S&P500 ETF | 464287200 | 199,121,000 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | ||
| ISHARES TR | IBOXX INV CP ETF | 464287242 | 51,090,000 | 500,000 | SH | Call | SOLE | 55,000 | 0 | 445,000 | |
| SPDR SERIES TRUST | ST STR P500ETF | 78464A854 | 4,036,507,200 | 44,970,000 | SH | SOLE | 0 | 0 | 44,970,000 | ||
| WARNER BROS DISCOVERY INC | COM SER A | 934423104 | 508,416 | 16,427 | SH | SOLE | 16,427 | 0 | 0 | ||